Thus, we speculate that the TREM-1-TLR2/4-MyD88 signaling pathway may promote hepatic inflammation and fibrosis in NASH via modulation of macrophage polarization. This evidence concerns the gene MYD88 and metabolic dysfunction-associated steatohepatitis.